Literature DB >> 3297107

Histoincompatible bone marrow transplants in humans.

R A Clift, R Storb.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3297107     DOI： 10.1146/annurev.iy.05.040187.000355

Source DB:  PubMed          Journal:  Annu Rev Immunol        ISSN： 0732-0582            Impact factor:   28.527


× No keyword cloud information.
  10 in total

1.  Induction of transplantation tolerance to fully mismatched cardiac allografts by T cell mediated delivery of alloantigen.

Authors:  Chaorui Tian; Xueli Yuan; Peter T Jindra; Jessamyn Bagley; Mohamed H Sayegh; John Iacomini
Journal:  Clin Immunol       Date:  2010-05-08       Impact factor: 3.969

Review 2.  Graft-versus-host disease of the intestine.

Authors:  G J Cox; G B McDonald
Journal:  Springer Semin Immunopathol       Date:  1990

3.  Simultaneous genotyping of DRB1/3/4/5 loci by oligonucleotide microarray.

Authors:  Ye Bang-Ce; Chu Xiaohe; Fan Ye; Li Songyang; Yin Bincheng; Zuo Peng
Journal:  J Mol Diagn       Date:  2005-11       Impact factor: 5.568

Review 4.  Anaesthetic implications for bone marrow transplant recipients.

Authors:  R A Stein; M J Messino; E A Hessel
Journal:  Can J Anaesth       Date:  1990-07       Impact factor: 5.063

5.  Transfusion support of the transplant patient.

Authors:  E Nisbet-Brown
Journal:  Can Fam Physician       Date:  1988-11       Impact factor: 3.275

Review 6.  Monoclonal antibodies as magic bullets.

Authors:  F M Brodsky
Journal:  Pharm Res       Date:  1988-01       Impact factor: 4.200

7.  Graft-versus-host disease can be separated from graft-versus-lymphoma effects by control of lymphocyte trafficking with FTY720.

Authors:  Yong-Mi Kim; Teviah Sachs; Wannee Asavaroengchai; Roderick Bronson; Megan Sykes
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

8.  Induction of transplantation tolerance by combining non-myeloablative conditioning with delivery of alloantigen by T cells.

Authors:  Chaorui Tian; Xueli Yuan; Jessamyn Bagley; Bruce R Blazar; Mohamed H Sayegh; John Iacomini
Journal:  Clin Immunol       Date:  2008-02-15       Impact factor: 3.969

9.  Interleukin 2 prevents graft-versus-host disease while preserving the graft-versus-leukemia effect of allogeneic T cells.

Authors:  M Sykes; M L Romick; D H Sachs
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

10.  Tolerance to MHC class II disparate allografts through genetic modification of bone marrow.

Authors:  P T Jindra; S Tripathi; C Tian; J Iacomini; J Bagley
Journal:  Gene Ther       Date:  2012-07-26       Impact factor: 5.250
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.